OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
OTUD5 promotes the growth of hepatocellular carcinoma by deubiquitinating and stabilizing SLC38A1
Yingnan Yang, Siying Jia, Ning Zhu, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 6
Yingnan Yang, Siying Jia, Ning Zhu, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 6
Showing 6 citing articles:
USP24 promotes hepatocellular carcinoma tumorigenesis through deubiquitinating and stabilizing TRAF2
Nana Zhou, Chaoqin Guo, Xiangyu Li, et al.
Biochemical Pharmacology (2024) Vol. 229, pp. 116473-116473
Open Access | Times Cited: 4
Nana Zhou, Chaoqin Guo, Xiangyu Li, et al.
Biochemical Pharmacology (2024) Vol. 229, pp. 116473-116473
Open Access | Times Cited: 4
The deubiquitinase OTUD5 stabilizes SLC7A11 to promote progression and reduce paclitaxel sensitivity in triple-negative breast cancer
Xizhi Liu, Zhiqiang Ma, Xin Jing, et al.
Cancer Letters (2024) Vol. 604, pp. 217232-217232
Closed Access | Times Cited: 4
Xizhi Liu, Zhiqiang Ma, Xin Jing, et al.
Cancer Letters (2024) Vol. 604, pp. 217232-217232
Closed Access | Times Cited: 4
Sodium butyrate increases USP5-mediated ubiquitination degradation of GPX4 and enhances anti-cancer efficacy of anti-PD-1 antibody
Qimeng Chang, Huarong Mao, Jin-Feng Feng, et al.
Biochemical Pharmacology (2025), pp. 116927-116927
Closed Access
Qimeng Chang, Huarong Mao, Jin-Feng Feng, et al.
Biochemical Pharmacology (2025), pp. 116927-116927
Closed Access
Deubiquitinases as novel therapeutic targets for diseases
Yali Xian, Jing Ye, Yu Tang, et al.
MedComm (2024) Vol. 5, Iss. 12
Open Access | Times Cited: 3
Yali Xian, Jing Ye, Yu Tang, et al.
MedComm (2024) Vol. 5, Iss. 12
Open Access | Times Cited: 3
GluOC Induced SLC7A11 and SLC38A1 to Activate Redox Processes and Resist Ferroptosis in TNBC
Jiaojiao Xu, Xue Bai, Keting Dong, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 739-739
Open Access
Jiaojiao Xu, Xue Bai, Keting Dong, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 739-739
Open Access
A novel benzofuran derivative of β-elemene (ZT-22) inhibits hepatocellular carcinoma cell growth via directly targeting HSPA6
Zhiqiang Luo, Huixia Fan, Tao Zhang, et al.
Chemico-Biological Interactions (2025), pp. 111514-111514
Closed Access
Zhiqiang Luo, Huixia Fan, Tao Zhang, et al.
Chemico-Biological Interactions (2025), pp. 111514-111514
Closed Access
Integration of single-cell and bulk RNA sequencing identifies and validates T cell-related prognostic model in hepatocellular carcinoma
Yuzhi Zhang, Haiyan Zhang, Lixin Liu
PLoS ONE (2025) Vol. 20, Iss. 5, pp. e0322706-e0322706
Open Access
Yuzhi Zhang, Haiyan Zhang, Lixin Liu
PLoS ONE (2025) Vol. 20, Iss. 5, pp. e0322706-e0322706
Open Access
